Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

ACR Board Lobbies Congress

Staff  |  July 1, 2007

ACR Board of Directors members recently spent time in Washington, D.C., discussing rheumatology-related issues with members of Congress, including Sen. Edward M. “Ted” Kennedy (D-Mass.). The senior senator from Massachusetts is the chair of the Senate Health, Education, Labor, and Pensions Committee, which oversees health legislation that affects rheumatologists.

Filed under:From the CollegeLegislation & Advocacy Tagged with:AdvocacyCongressLegislationPolitics

On Board with Baby

Sheri Polley  |  May 1, 2007

Rheumatology programs make strides in work–life balance support

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:Career developmentparenthoodPractice Managementrheumatologistwork-life balance

Minimally Invasive Total Hip Arthroplasty Audioconference

Staff  |  November 1, 2006

Want to learn more about total hip arthroplasty? Register for the January 17 ARHP Rheumatology Audioconference, Minimally Invasive and Percutaneous Total Hip Arthroplasties, where Alberto Bolanos, MD, will describe the latest advances in these procedures.

Filed under:Education & TrainingFrom the College Tagged with:arthroscopyEducationhip arthroplastyjoint replacementMeetingosteotomyTraining

How to Discuss Anti-Inflammatory Diets & Supplements with Your Patients

Emily Molina, MD  |  June 9, 2023

My patients ask me almost daily what kind of diet they should be on, or if there are certain supplements they should try. And a growing amount of evidence shows lifestyle and dietary factors may contribute to disease risk and outcomes in rheumatic disease. Thus, rheumatologists and rheumatology professionals are being called upon by patients…

Filed under:ConditionsHome SliderPatient Perspective Tagged with:Dietdietary supplementpatient communication

Integration of Complementary & Conventional Care for Patients with Musculoskeletal Disorders

Vanessa Caceres  |  May 8, 2023

Studies related to acupuncture and tai chi show some benefits for patients with musculoskeletal disorders, such as fibromyalgia and osteoarthritis. When patients ask about these integrative health approaches, rheumatologists should recommend they use qualified, experienced practitioners.

Filed under:ConditionsDrug Updates Tagged with:ACR on AirACR on Air podcastAcupunctureAlternative Medicinecomplementary medicinemeditationmindfulnesstai chi

Drug Safety: Fasinumab Evaluated in Clinical Trials, Plus Celecoxib May Not Pose Increased Heart Attack or Stroke Risk

Michele B. Kaufman, PharmD, BCGP  |  May 15, 2018

After an independent review, ongoing clinical trials investigating the safety of fasinumab for treating hip or knee OA will discontinue the use of higher fasinumab doses…

Filed under:Drug Updates Tagged with:celecoxib (Elyxyb)Drug SafetyfasinumabFDAhipkneeKnee Osteoarthritis (OA)Nonsteroidal anti-inflammatory drugs (NSAIDs)PainPain ManagementU.S. Food and Drug Administration (FDA)

2014 ACR/ARHP Annual Meeting: Alive and Growing

Susan Bernstein  |  February 1, 2015

Bone disorders play role in development of osteoarthritis pain, progression

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)BernsteinboneOsteoarthritisResearch

New Insights into CPPD

Robert Terkeltaub, MD  |  October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:DiseaseResearchTreatment

A&R and AC&R Abstracts: Bisphosphonates

Staff  |  February 3, 2012

Want to learn more about bisphosphonates and fractures? Check out these abstracts from Arthritis & Rheumatism and Arthritis Care & Research.

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bisphosphonatesbonehip replacementimagingOsteoporosispatient careResearchrheumatologist

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 12, 2011

Information on New Approvals and Medication Safety

Filed under:AnalgesicsDrug Updates Tagged with:ApprovalsDrugsFDAPipelineSafety

  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences